Chemoinformaics analysis of nitrosochloride
| Molecular Weight | 170.296 | nRot | 8 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 16 |
| Exact Molecular Weight | 170.167 | nRing | 0 |
| Solubility: LogS | -3.9 | nHRing | 0 |
| Solubility: LogP | 6.89 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 33.8414 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.154 |
| Synth | 4.086 |
| Natural Product Likeliness | 2.195 |
| NR-PPAR-gamma | 0.842 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.899 |
| Pgp-sub | 0.435 |
| HIA | 0.151 |
| CACO-2 | -4.743 |
| MDCK | 0.0000188 |
| BBB | 0.013 |
| PPB | 0.899535 |
| VDSS | 1.968 |
| FU | 0.0867728 |
| CYP1A2-inh | 0.256 |
| CYP1A2-sub | 0.499 |
| CYP2c19-inh | 0.739 |
| CYP2c19-sub | 0.129 |
| CYP2c9-inh | 0.923 |
| CYP2c9-sub | 0.912 |
| CYP2d6-inh | 0.281 |
| CYP2d6-sub | 0.149 |
| CYP3a4-inh | 0.211 |
| CYP3a4-sub | 0.25 |
| CL | 4.894 |
| T12 | 0.083 |
| hERG | 0.006 |
| Ames | 0.055 |
| ROA | 0.412 |
| SkinSen | 0.302 |
| Carcinogencity | 0.268 |
| EI | 0.015 |
| Respiratory | 0.432 |
| NR-Aromatase | 0.712 |
| Antiviral | No |
| Prediction | 0.748363 |